Protein-bound uremic solutes: The forgotten toxins

被引:108
作者
Vanholder, R [1 ]
De Smet, R [1 ]
Lameire, N [1 ]
机构
[1] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, B-9000 Ghent, Belgium
关键词
uremic toxicity; dialysis; solute removal; p-cresol; CMPF; indoxyl sulfate; homocysteine; hippuric acid;
D O I
10.1046/j.1523-1755.2001.59780266.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The present concept of dialysis focuses mainly on the removal of small water-soluble compounds, and also, the currently applied kinetic parameters of dialysis adequacy are based on the behavior of water-soluble compounds. Nevertheless, many of the currently known biological effects in uremia are attributable to compounds with different physicochemical characteristics, and among these, protein-bound solutes play an important role. In this article, we review the characteristics and consequences of changes in protein binding in uremia, as well as the toxicity of the protein-bound uremic solutes 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), indoxyl sulfate, hippuric acid, homocysteine, and p-cresol. Starting from the example of p-cresol, we then summarize the impact of protein-binding on dialytic removal, whereby it is concluded that this removal is largely hampered by this protein-binding compared with that of classic markers such as urea and creatinine. Alternative removal strategies, such as strategies to modify intestinal generation or absorption, are considered.
引用
收藏
页码:S266 / S270
页数:5
相关论文
共 37 条
[1]  
Abreo K, 1997, J AM SOC NEPHROL, V8, P935
[2]   HYPERHOMOCYSTEINEMIA AND TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN END-STAGE RENAL-DISEASE PATIENTS ON DIALYSIS - A CASE-CONTROL STUDY [J].
BOSTOM, AG ;
SHEMIN, D ;
LAPANE, KL ;
MILLER, JW ;
SUTHERLAND, P ;
NADEAU, M ;
SEYOUM, E ;
HARTMAN, W ;
PRIOR, R ;
WILSON, PWF ;
SELHUB, J .
ATHEROSCLEROSIS, 1995, 114 (01) :93-103
[3]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[4]   Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia [J].
Costigan, MG ;
Lindup, WE .
KIDNEY INTERNATIONAL, 1996, 49 (03) :634-638
[5]  
Costigan MG, 1996, NEPHRON, V73, P169
[6]   A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure [J].
De Smet, R ;
David, F ;
Sandra, P ;
Van Kaer, J ;
Lesaffer, G ;
Dhondt, A ;
Lameire, N ;
Vanholder, R .
CLINICA CHIMICA ACTA, 1998, 278 (01) :1-21
[7]   Study by means of high-performance liquid chromatography of solutes that decrease theophylline protein binding in the serum of uremic patients [J].
De Smet, R ;
Vogeleere, P ;
Van Kaer, J ;
Lameire, N ;
Vanholder, R .
JOURNAL OF CHROMATOGRAPHY A, 1999, 847 (1-2) :141-153
[9]  
DeSmet R, 1997, KIDNEY INT, V52, pS8
[10]   CORRELATION BETWEEN REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND PLASMA-PROTEIN BINDING [J].
GANANSIA, J ;
BIANCHETTI, G ;
THENOT, JP .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 421 (01) :83-90